Alumis

Merged

Transform Therapies, Reimagine Lives

Public · South San Francisco, United States · Founded 2021 · $459.0M raised

Employees
201–500
Founded
2021
Business Model
B2B
Website
alumis.com
Total Funding
$459.0M
Last Round
$259.0M Series CMar 2024
Rounds
2
Type
Public

About

Alumis is a clinical-stage biopharmaceutical company advancing a late-stage portfolio of next-generation oral targeted therapies for patients with immune-mediated diseases including psoriasis, lupus, and thyroid eye disease. The company's precision approach leverages proprietary data analytics to optimize clinical outcomes across a broad range of conditions.

Summary

Alumis is a Healthcare company based in South San Francisco, United States, founded in 2021. It has raised $459.0M in total across 2 rounds, most recently a $259.0M Series C round in Mar 2024. Investors include Foresite Capital, Samsara BioCapital and venBIO Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOJun 2024
$345.1M

Sign up to see all 3 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alumis on Indexed.vc
<a href="https://indexed.vc/companies/acelyrin"><img src="https://indexed.vc/api/badge/company/acelyrin" alt="Alumis on Indexed.vc" width="260" height="76" /></a>